Cambridge Capital Group

"This funding marks an important step in commercialising our Flip product platform and validating new assays with strategic partners across sectors where rapid, decentralised testing can make a meaningful difference,. Built on years of scientific and engineering development, Flip is designed to give researchers faster, simpler tools for detecting pathogens and contaminants, helping to prevent disease and protect products, biological processes and the environment."

"The Spotta platform built by Robert, Neil and the team delivers a real solution which can completely turn the insect pest control industry on its head. With their smart 24/7 monitoring enabling customers to precision target treatment for the first time. It’s a solution that protects people and crops but also hugely reduces the cost and environmental impact of treatment."

"This latest round of investment is a great recognition of our success to date, with new and existing investors confirming the strength of our technology. Since 2016, CGD has grown significantly and we are thrilled to be in a position to deliver several products to market, following decades of industry-leading research in reliability of power devices. This investment will allow us to supplement our experienced team with additional experts and expand our markets globally, creating more sustainable electronics worldwide."